{
    "nct_id": "NCT05241249",
    "official_title": "Phase II, Neoadjuvant Study of Parasympathetic Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Borderline Resectable Pancreatic Adenocarcinoma",
    "inclusion_criteria": "* Pancreatic Ductal Adenocarcinoma\n* Plan for neoadjuvant chemotherapy\n* Available diagnostic tissue adequate for biomarker analysis\n* Ability to tolerate PO meds and comply with study procedures\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Metastatic disease\n* Evidence of GI obstruction\n* Baseline bradycardia (HR<55) or hypotension (systolic blood pressure<90)\n* Use of acetylcholinesterase inhibitors\n* Medical conditions including: hyperthyroidism, active/symptomatic coronary artery disease, seizure disorder, peptic ulcer disease.",
    "miscellaneous_criteria": ""
}